Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Weigao Group Medical Polymer Co's quarterly Accounts Payable
increased
from Dec. 2024 (HK$4,585 Mil) to Jun. 2025 (HK$4,595 Mil) but then
declined
from Jun. 2025 (HK$4,595 Mil) to Dec. 2025 (HK$2,287 Mil).
Shandong Weigao Group Medical Polymer Co's annual Accounts Payable
declined
from Dec. 2023 (HK$4,725 Mil) to Dec. 2024 (HK$4,585 Mil) and
declined
from Dec. 2024 (HK$4,585 Mil) to Dec. 2025 (HK$2,287 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Group Medical Polymer Co Accounts Payable Chart
Shandong Weigao Group Medical Polymer Co Annual Data
Shandong Weigao Group Medical Polymer Co Accounts Payable Calculation
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
What does a Accounts Payable of HK$2,287 Mil mean?
Shandong Weigao Group Medical Polymer Co (HKSE:01066) has a Accounts Payable of HK$2,287 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors.
Is Shandong Weigao Group Medical Polymer Co's Accounts Payable too high?
Shandong Weigao Group Medical Polymer Co's current Accounts Payable is HK$2,287 Mil. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Accounts Payable compare to ISRG and BDX?
Shandong Weigao Group Medical Polymer Co's Accounts Payable of HK$2,287 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current Accounts Payable is HK$2,287 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (HKSE:01066) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$6.29, compared to a current price of HK$3.17 — trading 49.7% below its estimated fair value. The current Accounts Payable is HK$2,287 Mil. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (HKSE:01066), the current Accounts Payable is HK$2,287 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Weigao Group Medical Polymer Co (HKSE:01066) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued.
The current stock price of HK$3.17 is trading 49.7% below its estimated GF Value™ of HK$6.29.
GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.
Key valuation signals for HKSE:01066:
Accounts Payable: HK$2,287 Mil
GF Value™: HK$6.29 vs. price of HK$3.17 (49.7% below fair value)
No single metric tells the full story. See the HKSE:01066 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
84GF Score
Get the complete analysis for HKSE:01066
Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01066 has been successfully added to your 
